THIS ALONE IS WORTH THE PRICE OF ADMISSION, IMO:
ATNM recently apponted Niva Almaula, Ph.D. as Chief Business Officer...having most recently worked as Head, Business Development at Advanced Accelerator Applications, Inc., a nuclear medicine company acquired by Novartis for $3.9 billion in January 2018.